Verition Fund Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
125,345
+90,308
| +258% | +$846K | 0.01% | 1760 |
|
|
2025
Q1 | $430K | Buy |
+35,037
| New | +$430K | ﹤0.01% | 2059 |
|
|
2024
Q4 | – | Sell |
-79,341
| Closed | -$1.53M | – | 2775 |
|
|
2024
Q3 | $1.53M | Sell |
79,341
-65,225
| -45% | -$1.26M | 0.01% | 1111 |
|
|
2024
Q2 | $2.97M | Sell |
144,566
-202,296
| -58% | -$4.15M | 0.02% | 719 |
|
|
2024
Q1 | $8.26M | Buy |
346,862
+203,596
| +142% | +$4.85M | 0.06% | 343 |
|
|
2023
Q4 | $3.1M | Buy |
143,266
+128,266
| +855% | +$2.77M | 0.02% | 551 |
|
|
2023
Q3 | $218K | Buy |
+15,000
| New | +$218K | ﹤0.01% | 1589 |
|
|
2022
Q4 | – | Sell |
-10,737
| Closed | -$258K | – | 2125 |
|
|
2022
Q3 | $258K | Buy |
+10,737
| New | +$258K | ﹤0.01% | 1796 |
|
|
2021
Q1 | – | Sell |
-88,595
| Closed | -$1.97M | – | 1615 |
|
|
2020
Q4 | $1.97M | Buy |
+88,595
| New | +$1.97M | 0.02% | 300 |
|